Table 1.
Antimicrobial susceptibility profile of K. cowanii from a cholecystitis
| Antibiotic substance | MICa [mg/mL] | Interpretationb |
|---|---|---|
| Ampicillin | ≥ 256 | R |
| Ampicillin/Sulbactam | ≤ 2 | S |
| Cefoxitin | 4 | Wildtype |
| Piperacillin | 8 | S |
| Piperacillin/Tazobactam | ≤ 0,5 | S |
| Fosfomycin | ≥ 64 | R |
| Meropenem | ≤ 0.0032 | S |
| Ciprofloxacin | ≤ 0.04 | S |
| Colistin | ≤ 1 | S |
aMICs as determined by Etest and broth microdilution for K. cowanii clinical isolate
bInterpretation according to EUCAST criteria for Enterobacterales (The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2018. http://eucast.org)